All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Cardiac toxicity of targeted therapies used in the treatment for solid tumours: a review

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F12%3A%230000374" target="_blank" >RIV/00209805:_____/12:#0000374 - isvavai.cz</a>

  • Result on the web

    <a href="http://link.springer.com.proxy.mzk.cz/article/10.1007%2Fs12012-012-9164-0" target="_blank" >http://link.springer.com.proxy.mzk.cz/article/10.1007%2Fs12012-012-9164-0</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1007/s12012-012-9164-0" target="_blank" >10.1007/s12012-012-9164-0</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Cardiac toxicity of targeted therapies used in the treatment for solid tumours: a review

  • Original language description

    Cardiotoxicity associated with conventional cytostatics is a known phenomenon and is related to their general cytotoxic effects. This damage to the myocardium is usually irreversible. Despite the attempts to optimize safety profile of targeted anticancerdrugs during their development, evidence shows that these new treatment modalities also have cardiotoxic potential or may adversely affect vascular system. Over the last years, a significant number of these agents have been introduced in medical practice. Arterial hypertension, arrhythmias, left ventricular dysfunction and a heart failure are the most frequent cardiovascular adverse effects of targeted anticancer agents, but this toxicity seems to be reversible. To enable early interventions and to minimize these cardiovascular adverse effects, health care professionals have to be well-informed and familiar with the safety profiles of the drugs they administered, the patient's cardiovascular condition and co-morbidities, and they must

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    Z - Vyzkumny zamer (s odkazem do CEZ)

Others

  • Publication year

    2012

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Cardiovascular toxicology

  • ISSN

    1530-7905

  • e-ISSN

  • Volume of the periodical

    12

  • Issue of the periodical within the volume

    3

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    17

  • Pages from-to

    191-207

  • UT code for WoS article

    000306739100001

  • EID of the result in the Scopus database